Author

Katelyn L. O’Neill

Fred and Pamela Buffett Cancer CenterORCID 0009-0008-8925-239XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell signaling & trafficking· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Raymond C. BerganiD· 3 shared Fangfang QiaoiD· 2 shared Johnny W. Zigmond· 2 shared Weining CheniD· 2 shared Abhinandan PattanayakiD· 1 shared Amarnath NatarajaniD· 1 shared Chittibabu GudaiD· 1 shared Henry C.-H. LawiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Raymond C. BerganORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyProteomesPeer-reviewedAug 28, 2026

Integrative Proteomic Analysis Implicates Inhibition of Intracellular Protein Trafficking in Therapy-Induced Migrastasis in Prostate Cancer

Weining Chen, Saadyeh Rashidi, Henry C.-H. Law…·Raymond C. Bergan

This paper uses proteomic analysis to show that KBU2046 induces migrastasis in prostate cancer by inhibiting intracellular protein trafficking and altering signaling dynamics.

DOI 10.3390/proteomes14030045

humanproteomics

𝕏 PostBluesky

Cancer BiologyCellsPeer-reviewedJan 16, 2026

HSP90α and KLK6 Co-Regulate Stress-Induced Prostate Cancer Cell Motility

Katelyn L. O’Neill, Johnny W. Zigmond, Raymond C. Bergan

The paper shows that stress increases eHSP90 and KLK6 in prostate cancer cells, which together reduce MMP-2 activity and cell motility.

DOI 10.3390/cells15020166

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMay 20, 2025

A New Class of Precision Therapeutics that Inhibit Prostate Cancer Mediated Bone Destruction

Fangfang Qiao, Ryan R. Gordon, Abhinandan Pattanayak…·Raymond C. Bergan

This paper develops BTE-EN1, a compound that inhibits prostate cancer-mediated bone destruction by targeting cell motility and osteoclast activity, showing efficacy in mice.

1 citation

mouseexperimental assay

𝕏 PostBluesky